New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo
- 24 February 2009
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 29 (3) , 514-546
Abstract
Vitiligo is a progressive depigmenting disorder affecting 0.5–2% of the population worldwide in which destruction of functional melanocytes from epidermis is a composite of multiple processes influencing melanocyte function and survival. A number of studies have recently reported that the treatment with vitamin D compounds or their combination with ultraviolet light or corticosteroids enhances repigmentation in vitiligo; however, the causal relationship at the cellular and molecular levels has not so far been investigated. This review details the main intracellular pathways through which vitamin D ligands alone or in different combinations may contribute to pigment restoration in vitiligo, outlines the most recent achievements in vitiligo treatment using vitamin D analogs, and compares their efficacy with other treatment regimens in vitiligo. Based on the reviewed literature and data, we foresee the need for designing new vitamin D compounds to achieve maximal therapeutic efficacy. Such compounds should have high selectivity for melanocytes, stimulatory effects on melanogenesis, and minimal suppressive effects on melanocyte growth. An approach combining clinical investigations and focused research on the cellular and molecular mechanisms of vitiligo repigmentation will lead to finding better treatments for this disease. © 2009 Wiley Periodicals, Inc. Med Res Rev, 29, No. 3, 514‐546, 2009Keywords
This publication has 170 references indexed in Scilit:
- Effects of Solar Ultraviolet Radiation on Engineered Human Skin Equivalent Containing Both Langerhans Cells and Dermal Dendritic CellsTissue Engineering, 2007
- Current state of vitiligo therapy – evidence‐based analysis of the literatureJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2007
- Therapeutic implications of autoimmune vitiligo T cellsAutoimmunity Reviews, 2006
- Mechanisms of action of topical therapies and the rationale for combination therapyJournal of the American Academy of Dermatology, 2005
- Noncalcemic Actions of Vitamin D Receptor LigandsEndocrine Reviews, 2005
- 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damageJournal of Photochemistry and Photobiology B: Biology, 2005
- Molecular pathways involved in the anti‐apoptotic effect of 1,25‐dihydroxyvitamin D3 in primary human keratinocytesJournal of Cellular Biochemistry, 2004
- Potent Inhibition of Dendritic Cell Differentiation and Maturation by Vitamin D AnalogsBiochemical and Biophysical Research Communications, 2000
- Vitamin D nutrition increases skin tyrosinase response to exposure to ultraviolet radiationMolecular and Cellular Endocrinology, 1982
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981